|Articles|May 1, 2018
- BioPharm International-05-01-2018
- Volume 31
- Issue 5
BioPharm International, May 2018 Issue (PDF)
Click the title above to open the BioPharm International May 2018 issue in an interactive PDF format.
Advertisement
Articles in this issue
over 7 years ago
Harmonization of Batch Recordsover 7 years ago
Gottlieb Tackles Tough Issues in First Year at FDAover 7 years ago
Understanding Validation and Technical Transfer, Part 2over 7 years ago
Leveraging Data for Better Biopharmaceutical Process Controlover 7 years ago
Key Ingredients to Healthcare’s Futureover 7 years ago
NIST Spectroscopic Measurement Standardsover 7 years ago
Managing Uncertainty in Continuous Biomanufacturingover 7 years ago
Putting Viral Clearance Capabilities to the Testover 7 years ago
CDMOs Driving Emerging Bio/Pharma SuccessNewsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
Why AI-Native Cell Manufacturing Is the Future of Drug Discovery (Part 1)
2
GSK Advances Vaccine Delivery and Hepatitis B Treatment
3
CDC Revises Childhood Immunization Schedule, Shifting Demand Dynamics
4
Industry Outlook 2026: Biopharma Braces for Economic Upheaval While Eyeing AI-Driven Transformation (Part 1)
5
